OPRM1 and respiratory depression: As [Nal(2’)4]CJ-15,208 displayed bifunctional MOR agonist/DOR antagonist activity, it was then assessed for potential liabilities produced by standard MOR opioid agonists, specifically antinociceptive tolerance, respiratory depression, hyperlocomotion, and conditioned place preference.